Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. ChEmpower
ChEmpower is an advanced materials company specializing in the development of chemically reactive, abrasive-free planarization pads for semiconductor manufacturing. Their innovative technology aims to enhance chip yields, reduce defects, and promote sustainability by eliminating the use of abrasives and slurries in the polishing process.
- Sector: Information Technology
- Last known transaction date: Series A Venture, $18.7M, April 2025
- Why timing suggests a near-term transaction: ChEmpower's $18.7M Series A is a healthy raise for an IT venture, providing roughly 18–24 months of runway to scale the team, build out product, and pursue enterprise customer acquisition. That timeline places a Series B squarely in the 2026–2027 window, and if they're hitting growth benchmarks in a competitive IT environment, they may move to market on the earlier end to capitalize on momentum.
View all private company data in Dakota Marketplace.
2. Ovo Labs
Ovo Labs is a biotechnology company specializing in developing therapeutics aimed at enhancing egg quality to improve in vitro fertilization (IVF) success rates. The company is headquartered in Oberschleißheim, Bayern, Germany, and operates with a small team of 1-10 employees. Their primary focus is on biopharmaceutical product research, particularly in the field of reproductive health. In April 2025, Ovo Labs secured £4 million in seed funding to advance their mission of extending women's fertility windows and improving IVF outcomes for women over 35. The funding round was led by LocalGlobe and Creator Fund, with participation from Blue Wire Capital, Antonio Pellicer, and Ahren Innovation Capital. This investment is expected to support the development and commercialization of their innovative fertility treatments.
- Sector: Health Care
- Last known transaction date: Seed Venture, $5.335M, April 2025
- Why timing suggests a near-term transaction: Ovo Labs' $5.335M seed round is a moderate raise for a healthcare venture, where early-stage capital is quickly absorbed by product development, regulatory groundwork, and clinical validation — all of which are table stakes before a Series A becomes viable. This positions Ovo Labs for a Series A raise within the next 12–18 months, particularly if they're able to demonstrate early clinical or commercial proof points that justify a larger growth round.
View all private company data in Dakota Marketplace.
3. Zest Equity
Zest Equity is a UAE-based fintech startup founded in 2021 by Rawan Baddour and Zuhair Shamma. The company offers a digital platform designed to streamline private market transactions, enabling founders, investors, and other stakeholders to execute deals efficiently and transparently. By digitizing processes such as deal structuring, investor onboarding, and transaction execution, Zest Equity aims to reduce the complexities and costs associated with traditional private market dealings.
- Sector: Financials
- Last known funding round: Seed Venture, $4.3M, April 2025
- Why timing suggests a near-term transaction: Zest Equity's $4.3M seed round provides a relatively tight runway for a fintech play, where compliance infrastructure, licensing, and customer acquisition in the financial services space tend to be more expensive and time-consuming than in other sectors. This points to a Series A raise likely within the next 12–18 months as they work to build out their regulatory foundation and demonstrate early traction with financial institution or investor clients.
View all private company data in Dakota Marketplace.
4. NOUS Research
NOUS Research is an artificial intelligence company and open-source research organization focusing on decentralized AI. Founded in 2022 and formally established in 2023, the company develops human-centric language models and simulators, emphasizing open-source, human-compatible models that challenge conventional closed-model approaches.
- Sector: Information Technology
- Last known funding round: Series A Venture, $50M, April 2025
- Why timing suggests a near-term transaction: NOUS Research's $50M venture round signals they're operating at meaningful scale within the AI/IT space, but for a research-intensive technology company, $50M can be consumed rapidly by compute costs, talent acquisition, and model development. Depending on their burn rate and growth trajectory, a follow-on raise — likely in the $100M+ range — could come within 18–24 months as they push toward commercialization or expanded research capabilities.
View all private company data in Dakota Marketplace.
5. Cipher Surgical
Cipher Surgical is a medical device company established in 2010, specializing in laparoscopic surgical technology. Their flagship product, the OpClear® platform, enhances visibility during minimally invasive surgeries by providing continuous lens cleaning, thereby reducing surgical delays and improving patient outcomes.
- Sector: Health Care
- Last known funding round: Series A, $10M, April 2025.
- Why timing suggests a near-term transaction: Cipher Surgical's $10M Series A is a lean raise for a medical device company where commercialization, international market expansion, and next-generation product development are all capital-intensive priorities. As the company scales the OpClear® platform globally and demonstrates commercial traction in new markets, a Series B raise is likely within the next 18–24 months to support the larger capital base needed to compete at scale.
View all private company data in Dakota Marketplace.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
